Zongwei Wang

7PUBLICATIONS
9CO-AUTHORS
Medical bacteriologyPharmacogenomicsBiologically active moleculesReaction engineering (excl. nuclear reactions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer.

|Jan 07, 2026
SRD5A2 and emerging therapies in androgen-driven disorders.

Zongwei Wang, Boqing Gu, Christina Sharkey

|Jun 12, 2025
Stromal SRD5A2 promotes prostate growth through WNT5A-LEF1-IGF1 signaling in benign prostatic hyperplasia.

Christina Sharkey, Boqing Gu, Xingbo Long

|Apr 12, 2024
Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2.

Christina Sharkey, Xingbo Long, Ra'ad Al-Faouri

|Mar 06, 2020
Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.

Zongwei Wang, Tuo Deng, Xingbo Long

|Feb 08, 2020
Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland.

Bichen Xue, Shulin Wu, Christina Sharkey

Pageof 2

Frequent Collaborators

2 joint publications

Douglas Strand

2 joint publications

Aria F Olumi

1 joint publications

Bichen Xue

1 joint publications

Christina Sharkey